Evidence-based Complementary and Alternative Medicine · 2016 · 25 citations · 14 references
MedicineNeurosciencePharmacologyMemoryNeuropharmacologyPsychopharmacologyCholinergic NeurochemistryCognitive ImpairmentNeuromodulationNeuroprotectionAcetylcholinesterase FunctionAche InhibitionAntioxidant PropertiesFruit AntioxidantsFruit PhytochemicalsNeuroprotective Natural ProductsRodent LearningRodent Memory
Aronia melanocarpa (A. melanocarpa) berries are a fruit with a marked antioxidant effect. The objective of this study was to confirm the effect of A. melanocarpa berries extract against scopolamine-induced memory impairment in mice using the Morris water maze and passive avoidance test. Moreover, we determined a possible mechanism of the cognitive-enhancing effect involving AChE activity and BDNF and p-CREB expression in the hippocampus of mice. A. melanocarpa berries extract attenuated the learning and memory impairment induced by scopolamine in the Morris water maze (79.3 ± 0.8 s of 200 mg/kg and 64.4 ± 10.7 s of 400 mg/kg on day 4) and passive avoidance tests (46.0 ± 41.1 s of 200 mg/kg and 25.6 ± 18.7 s of 400 mg/kg). A. melanocarpa berries extract reduced the acetylcholinesterase level in the hippocampus of scopolamine-injected mice and increased BDNF and p-CREB expression in the hippocampus. The major compound, cyanidin-3-O-galactoside, also reversed memory impairment. These results showed that A. melanocarpa berries extract improved memory impairment by inhibiting AChE and increasing BDNF and p-CREB expression, and cyanidin-3-O-galactoside may be responsible for the effect of A. melanocarpa berries extract.
14
A new and rapid colorimetric determination of acetylcholinesterase activity
George L. Ellman, K. Diane Courtney, Valentino Andres et al. · Biochemical Pharmacology · 1961 · 26.9K citations
Cleavage of Amyloid β Peptide During Constitutive Processing of Its Precursor
Fred Esch, Pamela S. Keim, Eric C. Beattie et al. · Science · 1990 · 1.4K citations